Caitong International Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Caitong International Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.9K	Buy	+25,982	New	+$87K	0.01%	705
2025 Q3	–	Sell	-1,248	Closed	-$3.02K	–	2213
2025 Q2	$3.02K	Buy	+1,248	New	+$1.69K	﹤0.01%	1233

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caitong International Asset Management's NBP Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 25,982 shares worth $63.9K. The stake represents 0.01% of the portfolio and ranks #705 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in NBP as recently as Q2 2025.

Caitong International Asset Management first reported a position in NBP in Q2 2025 and has held it in 2 quarters since. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Caitong International Asset Management held 25,982 shares of NovaBridge Biosciences American Depositary Shares worth $63.9K as of Q1 2026.
NovaBridge Biosciences American Depositary Shares was a new Caitong International Asset Management position in Q1 2026.
NovaBridge Biosciences American Depositary Shares made up 0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #705 holding.
Caitong International Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2025 and has held it in 2 quarters since.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.